Search
for
Sort by
Research 181–210 of 1000+
- The Immunological Intersection of Psoriasis and Autoimmune Diseases: Shared Pathways and Clinical Implications
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
- Intrinsic factors in the pathogenesis of hidradenitis suppurativa: Genetics, hormones, and the microbiome
- Immune therapies for alopecia areata: evidence and new perspectives
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review)
- Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Polysaccharides from the Sargassum and Brown Algae Genus: Extraction, Purification, and Their Potential Therapeutic Applications
- Cosmetopoeia of African Plants in Hair Treatment and Care: Topical Nutrition and the Antidiabetic Connection?
- Microneedles: Selected Applications for Pediatrics
- ALOPECIA AREATA: ASPECTOS FISIOLÓGICOS E AVANÇOS TERAPÊUTICOS – UMA REVISÃO DE LITERATURA
- Frontal Fibrosing Alopecia: An Observational Single-Center Study of 306 Cases
- Effect of surfactant type on the dyeability and color resistance of semi-permanent basic hair dye
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Controlled Delivery of T-box21 Small Interfering RNA Ameliorates Autoimmune Alopecia (Alopecia Areata) in a C3H/HeJ Mouse Model
- Calcitonin gene‐related peptide (CGRP) may award relative protection from interferon‐γ‐induced collapse of human hair follicle immune privilege
- Alopecia areata during Interferon Alpha-2b/Ribavirin Therapy
- Tumour Necrosis Factor Alpha, Interferon Gamma and Substance P Are Novel Modulators of Extrapituitary Prolactin Expression in Human Skin
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
- Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies
- Failure to induce alopecia areata in C3H/HeJ mice with exogenous interferon gamma
- Interferon β Secreted from Human Hair Dermal Papilla Cells Inhibits the Growth of Outer Root Sheath Cells Cultured in Vitro
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Cutaneous ulcers due to interferon seem not to be related to the dosage
- Alopecia universalis as a side effect of pegylated interferon α-ribavirin combination therapy for hepatitis C: a rare case report